Relationship between expression of Wilms' tumor gene, insulin-like growth factor I receptor and cell apoptosis in human pancreatic duct adenocarcinoma

Yong Gong,Qiu Zhao,Fang Yang,Yuhua Wang,Song-Lin Ma
2006-01-01
World Chinese Journal of Digestology
Abstract:AIM: To investigate the roles of Wilms' tumor gene (WT1), insulin-like growth factor I receptor expression (IGF-IR) and cell apoptosis as well as their correlations in human pancreatic duct adenocarcinoma. METHODS: Immunohistochemical analysis was used to detect the expression of WT1 and IGF-IR in human pancreatic duct adenocarcinoma (n = 49) and normal pancreatic tissues (n = 15). The cell apoptosis of pancreatic duct adenocarcinoma was estimated by terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) method and apoptosis index (AI) was calculated. RESULTS: In normal pancreatic tissues, the positive rates of WT1, IGF-IR were 26.67% (4/15), 40.00% (6/15), respectively, and in pancreatic duct adenocarcinoma their positive rates were 71.43% (35/49), 77.55% (38/49), repectively. There were significant differences between cancer and normal tissues (P < 0.05). A positive relationship existed between the expression of WT1 and IGR-IR in pancreatic duct adenocarcinoma (r = 0.385, P < 0.05). The values of AI were 0.41 ± 0.13 and 5.93 ± 4.18 in the normal tissues and adenocarcinoma, respectively, and there was also a significant difference between them (P < 0.05). The value of AI was increased with the rising of tumor differentiation degree in adenocarcinoma, and it was lower in the IGF-IR positive group than that in the negative group (4.11 ± 3.68 vs 12.21 ± 5.67, P < 0.01). CONCLUSION: The apoptosis is inhibited in pancreatic duct adenocarcinoma, in which the over-expression of WT1 and IGF-IR may play crucial roles.
What problem does this paper attempt to address?